Bharat Biotech mentioned right this moment that it had adopted a “step-by-step” strategy in the direction of contracts and regulatory approvals with Brazil amid investigations within the nation to the deal for 20 million Covaxin doses.
Brazil has determined to droop a $ 324 million contract, which has engulfed President Jair Bolsonaro in accusations of irregularities, on the recommendation of the federal comptroller.
“In the specific case of procurement of Covaxin by the Ministry of Health, Brazil, since the first meetings during Nov 2020 until June 29, a step-by-step approach has been followed towards contracts, and regulatory approvals, during this eight-month-long process,” Bharat Biotech mentioned in an announcement.
“EUA received on June 4. As of June 29, Bharat Biotech has not received any advance payments nor supplied any vaccines to MOH Brazil. Bharat Biotech has followed a similar approach towards contracts, regulatory approvals and supplies in several countries worldwide, where Covaxin is being supplied successfully,” mentioned the Hyderabad-based vaccine maker.
(THIS STORY HAS NOT BEEN EDITED BY INDIA07 TEAM AND IS AUTO-GENERATED FROM A SYNDICATED FEED.)